title: Can hypercalcaemia be avoided during oral calcitriol pulse therapy of secondary hyperparathyroidism in haemodialysis patients?
authors.forename: M
authors.initials: M
authors.lastname: Szotkiewicz
authors.forename: Z
authors.initials: Z
authors.lastname: Zdrojewski
authors.forename: A
authors.initials: A
authors.lastname: Swima-Gillow
authors.forename: B
authors.initials: B
authors.lastname: Rutkowski
mesh_terms: D000284:Administration, Oral; D002117:Calcitriol / Q000008:administration & dosage / Q000009:adverse effects*; D002118:Calcium / Q000097:blood; D004334:Drug Administration Schedule; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced / Q000517:prevention & control*; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D002117:Calcitriol; D002118:Calcium